Benlysta 120 mg, Pulver zur Herstellung einer Infusionslösung
7680615320019
CH-61532
Pulver
Associated product:
BENLYSTA subst sèche 120 mg flac
1 / 2
google
Article details
- Package size
- 1
- Selling units
- 1
- Measure
- Durchstechflasche(n)
- Galenic form
- Pulver
- Galenic group
- Lösbar zur Einnahme
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
PRC
|
120.0 MG | Substance | Wirkstoff (Principe actif) |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 186.60
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/05/2015
Authorization holder
GlaxoSmithKline AG
6340 Baar
Authorization information
- Swissmedic authorization number
- 61532
- Drug name
- Benlysta, Pulver zur Herstellung einer Infusionslösung
- Galenic form
- PULPA
- ATC Code
- L04AG04
- Authorization status
- Z
- Dispensing category
- A
- First authorization
- 14/06/2012
- Authorization expiration date
- 31/12/9999
- IT Number
- 07.15.0.
- Domain
- Human medicine
Package details
- Description (FR)
- BENLYSTA subst sèche 120 mg flac
- Description (DE)
- BENLYSTA Trockensub 120 mg Durchstf
- Market launch
- 14/06/2012
- Narcotic (BTM)
- No
Other package sizes (1)
BENLYSTA subst sèche 400 mg flac
1 DUR
GTIN: 7680615320026